HISTORY OF SUCCESS PAVED WAY FOR GATES INSTITUTE AND ITS PROGRAMS

2007

Gates Program for Stem Cell Research established in honor of entrepreneur and philanthropist, Charles C. Gates. Dennis Roop, PhD, named founding director.

2010

Gates Program becomes Gates Center for Regenerative Medicine.

2015

Opening of the Gates Biomanufacturing Facility, an FDA Good Manufacturing Practices (GMP) compliant facility.

Launch of the Gates Grubstake Fund to finance promising research discoveries.

Creation of the Gates Summer Internship Program in regenerative medicine (GSIP) for college undergraduates.

2016

Gates Center partners with CU Department of Ophthalmology to establish CellSight ocular stem cell and regeneration program. Valeria Canto Soler, PhD, named director.

2017

Startup Toolbox established to provide entrepreneurial support to researchers.

2018

GBF achieves its first GMP run and readies its first shipment of clinical trial cancer treatments.

2019

Establishment of the EhlersDanlos Center of Excellence in partnership with Children’s Hospital Colorado and the CU School of Medicine.

2020

Launch of human clinical trials using CAR T cells developed at the CU School of Medicine and created at the Gates Biomanufacturing Facility—the first cellular immunotherapy project where the developmental science, the regulatory filing and approvals, the manufacturing process, and the infusion of patients in clinical trials were all performed at the CU Anschutz.

2022

Historic $200 million commitment announced to form Gates Institute. Terry Fry, MD, named inaugural director of the new organization, with Dennis Roop, PhD, remaining as associate director.